These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23172958)

  • 21. [Glycosylated hemoglobin and monitoring of diabetic retinopathy].
    Harada T; Tanabe Y; Kojima K; Harada K
    J Fr Ophtalmol; 1985; 8(4):315-9. PubMed ID: 4040539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
    Cappai G; Songini M; Doria A; Cavallerano JD; Lorenzi M
    Diabetologia; 2011 Jun; 54(6):1539-42. PubMed ID: 21380594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden.
    Larsson LI; Alm A; Bergenheim T; Lithner F; Bergström R
    Acta Ophthalmol Scand; 1999 Aug; 77(4):430-6. PubMed ID: 10463416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic determinants of variability in glycated hemoglobin (HbA(1c)) in humans: review of recent progress and prospects for use in diabetes care.
    Soranzo N
    Curr Diab Rep; 2011 Dec; 11(6):562-9. PubMed ID: 21975967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients.
    Shimo N; Yasuda T; Kaneto H; Katakami N; Kuroda A; Sakamoto F; Takahara M; Irie Y; Horikawa K; Miyashita K; Miyatsuka T; Yoshiuchi K; Kawamori D; Sakamoto K; Matsuoka TA; Kosugi K; Shimomura I; Matsuhisa M
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e41-3. PubMed ID: 25287616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting retinal neurodegeneration in people with diabetes: Findings from the UK Biobank.
    Channa R; Lee K; Staggers KA; Mehta N; Zafar S; Gao J; Frankfort BJ; Chua SYL; Khawaja AP; Foster PJ; Patel PJ; Minard CG; Amos C; Abramoff MD
    PLoS One; 2021; 16(9):e0257836. PubMed ID: 34587216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
    Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
    Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA(1c)) on exenatide treatment.
    Brooks AM; Lissett CA
    Diabet Med; 2009 Feb; 26(2):190. PubMed ID: 19236627
    [No Abstract]   [Full Text] [Related]  

  • 29. Obstructive sleep apnoea is associated with the development and progression of diabetic retinopathy, independent of conventional risk factors and novel biomarkers for diabetic retinopathy.
    Rudrappa S; Warren G; Idris I
    Br J Ophthalmol; 2012 Dec; 96(12):1535. PubMed ID: 23077225
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?
    Sabanayagam C; Liew G; Tai ES; Shankar A; Lim SC; Subramaniam T; Wong TY
    Diabetologia; 2009 Jul; 52(7):1279-89. PubMed ID: 19387611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of HbA(1c) for the diagnosis of diabetes.
    Bonora E
    Curr Diab Rep; 2011 Dec; 11(6):470-1. PubMed ID: 21927804
    [No Abstract]   [Full Text] [Related]  

  • 32. Progression of retinopathy is related to glycaemic control even in patients with mild diabetes mellitus.
    Henricsson M; Groop L; Heijl A
    Acta Ophthalmol Scand; 1996 Dec; 74(6):528-32. PubMed ID: 9017035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials.
    Lamoureux EL; Wong TY
    Diabetes Care; 2011 Apr; 34(4):1066-7. PubMed ID: 21447672
    [No Abstract]   [Full Text] [Related]  

  • 34. Worsening of diabetic retinopathy after improvement of glycemic control.
    Davis MD
    Arch Ophthalmol; 1998 Jul; 116(7):931-2. PubMed ID: 9682709
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.
    McCarter RJ; Hempe JM; Gomez R; Chalew SA
    Diabetes Care; 2004 Jun; 27(6):1259-64. PubMed ID: 15161772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between retinopathy development and systemic factors in type 2 childhood diabetes].
    Lee Z; Sato Y; Urakami T
    Nippon Ganka Gakkai Zasshi; 2007 May; 111(5):397-400. PubMed ID: 17536499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors for incidence and progression of diabetic retinopathy].
    Kawasaki R; Yamashita H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():178-82. PubMed ID: 15999703
    [No Abstract]   [Full Text] [Related]  

  • 38. N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes.
    Miralles JM; Corrales JJ; Garcia-Diez LC; Cabezas JA; Reglero A
    Clin Chim Acta; 1982 Jun; 121(3):373-8. PubMed ID: 7105401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus.
    Warram JH; Manson JE; Krolewski AS
    N Engl J Med; 1995 May; 332(19):1305-6. PubMed ID: 7708084
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of glycosylated hemoglobin on the choroidal thickness.
    Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M
    Int Ophthalmol; 2018 Oct; 38(5):1863-1869. PubMed ID: 28766280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.